PRECISION BIOSCIENCES INC Balance Sheet
DTIL|7 years of annual SEC 10-K data (FY2019-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$154M
FY2025
Cash
$111M
Cash and equivalents
Total Debt
N/A
FY2025
Shareholder Equity
$56M
FY2025
PRECISION BIOSCIENCES INC had $154M in total assets and $56M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Accrual-heavy earnings: Net income significantly exceeds operating cash flow
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $110.8M | $85.9M | $116.7M | $189.6M | $143.7M | $89.8M | $180.9M |
| Accounts Receivable | $0 | $229.0K | $901.0K | $720.0K | $488.0K | $10.0M | $965.0K |
| Current Assets | $118.7M | $95.0M | $136.4M | $199.1M | $161.8M | $105.6M | $193.7M |
| PP&E (Net) | $1.4M | $3.1M | $6.3M | $20.2M | $25.2M | $35.1M | $39.6M |
| Total Assets | $154.4M | $136.4M | $159.8M | $238.2M | $211.5M | $150.2M | $235.2M |
| Current Liabilities | $8.9M | $15.0M | $50.0M | $59.7M | $36.0M | $42.8M | $26.9M |
| Total Debt | - | - | - | $22.2M | $2.5M | - | - |
| Shareholders' Equity | $56.4M | $18.9M | $60.4M | $91.2M | $44.4M | $138.3M | $40.0M |